Avricore Health (AVCRF) Change in Accured Expenses (2009 - 2025)
Avricore Health (AVCRF) posted quarterly Change in Accured Expenses of -$214307.9 for Q3 2025, down 733.44% YoY from $33832.6 in Q3 2024, and down 4.46% sequentially from -$205161.9 in Q2 2025.
Avricore Health (AVCRF) Change in Accured Expenses (2009 - 2025) Analysis & Trends
Avricore Health has disclosed Change in Accured Expenses across 17 years of filings, most recently posting -$214307.9 for Q3 2025.
- In Q3 2025, Change in Accured Expenses fell 733.44% year-over-year to -$214307.9; the TTM figure through Sep 2025 stood at -$485825.9 (down 411.07% YoY), while the FY2025 annual figure was -$112490.7, up 2.77% from the prior year.
- Change in Accured Expenses slipped to -$214307.9 in Q3 2025, from -$205161.9 in the prior quarter.
- Over the last five years, Change in Accured Expenses for AVCRF reached as high as $216364.6 in Q3 2023 and fell as low as -$214307.9 in Q3 2025.
- The 5-year median for Change in Accured Expenses is -$3100.3 (2021), against an average of -$13547.3.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 1619.19% — and 2025, when it slumped 733.44%.
- A 5-year view of Change in Accured Expenses shows it stood at -$89959.6 in 2021, then soared by 80.24% to -$17773.0 in 2022, then sank by 384.7% to -$86146.3 in 2023, then soared by 139.27% to $33832.6 in 2024, then tumbled by 733.44% to -$214307.9 in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$214307.9, -$205161.9, and -$100188.7 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 235.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -322.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 98.23 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -47.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -214,307.91 |
| Sep 30, 2025 | -214,307.91 |
| Jun 30, 2025 | -205,161.93 |
| Jun 30, 2025 | -205,161.93 |
| Mar 31, 2025 | -100,188.71 |
| Mar 31, 2025 | -100,188.71 |
| Sep 30, 2024 | 33,832.61 |
| Sep 30, 2024 | 33,832.61 |
| Jun 30, 2024 | -108,239.51 |
| Jun 30, 2024 | -108,239.51 |
| Mar 31, 2024 | 65,492.97 |
| Mar 31, 2024 | 65,492.97 |
| Dec 31, 2023 | -86,146.33 |
| Dec 31, 2023 | -86,146.33 |
| Sep 30, 2023 | 216,364.59 |
| Sep 30, 2023 | 216,364.59 |
| Jun 30, 2023 | -38,747.26 |
| Jun 30, 2023 | -38,747.26 |
| Mar 31, 2023 | 41,121.94 |
| Mar 31, 2023 | 41,121.94 |